In non-small cell lung cancer (NSCLC), H3K18 lactylation promotes immune suppression by inducing pore membrane protein 121 (POM121), which increases MYC activity and programmed cell death-ligand 1 (PD-L1) expression [71]. This evidence concerns the gene MYC and non-small cell lung carcinoma.